Background
The progressive establishment of
Aedes albopictus, the tiger mosquito, in southern Europe at the beginning of the 90’s and its establishment in France in about 2004 have increased the potential health threat posed by these arthropods in temperate countries [
1]. Many tropical arboviral diseases transmitted by arthropod vectors, such as dengue fever (DEN hereafter), chikungunya (CHIK) and Zika (ZIKA) transmitted by
Aedes mosquitoes, are now also seen as emerging threats in temperate and sub-temperate regions. The Mediterranean basin, which offers suitable environmental conditions for mosquitoes, is considered to be at high risk for outbreaks of new arboviral diseases [
2]. Since 2010, sporadic cases and small outbreaks of DEN and CHIK viruses have been recorded in Western and Southern Europe [
3‐
8] A small outbreak of DEN with 15 cases took place in Croatia in 2010 [
9] followed by a much larger epidemic on the Portuguese Island of Madeira in 2012 [
10] with over 2,000 human cases. Autochtonous DEN transmission has been repeatedly reported in France as well since 2010 [
11‐
13]. To our knowledge, no autochthonous case of ZIKA has been declared on the sub-continent, despite sporadic sexual transmission of the virus reported in France [
14], Germany [
15] and Italy [
16]. Between early August and mid-September 2017, 17 autochtonous CHIK cases (15 confirmed and 2 probable) have been reported in two cities of the Var department, in the southeast of France. The primary case was imported via a return from Cameroon, in central Africa. This 2017 outbreak was the ninth episode of local autochtonous CHIK virus transmission in mainland France [
17]. After this outbreak the French national public health agency “Santé publique France” in charge of human health highlighted the need for public awareness and training campaigns targeting healthcare professionals.
Santé publique France regularly publishes information concerning, notably, these three infections. As a recent illustration, from May 1st to June 7th of 2019, 109 DEN, 12 CHIK and 1 ZIKA confirmed imported cases were reported in mainland France, with 40% of dengue cases originating from Réunion Island where a major DEN epidemic has been ongoing since the beginning of 2019. During the same period, no autochtone cases of DEN, CHIK and ZIKA were reported by this national health agency in mainland France [
18]. Although importation to Europe via travelers is well documented, the true risk of establishment of these three arboviral diseases after importation remains unknown. The risk of disease introduction into mainland France and Western Europe is exemplified by the massive flow of air transportation to and from tropical regions, notably to and from ultraperipherical regions, and by its increase through the years: in 2018 the number of passengers entering mainland France from these areas included 2,475,116 from Réunion Island (increase rate of 7,9% from 2017 to 2018), 2,446,234 from Guadeloupe (3,6%), 1,978,356 (2,4%), 1,393,849 from Tahiti (7,9%) and 538,782 from French Guiana (4,7%) among others [
19].
The first mathematical modeling study for the risk of DEN virus establishment in Europe was published recently [
20], and actually showed the risk to be low. However, climate change will increase the risk of arboviral diseases as the seasonal window for suitable temperature conditions for the settlement of
Aedes mosquitoes and viral transmission increases in Europe, and especially in Southern Europe [
21]. Furthermore, the number of travelers from DEN endemic and CHIK or ZIKA epidemic countries to Europe is increasing at an unprecedented rate. According to [
20], the highest number of DEN virus importations via air travelers are projected to occur in Germany, France and the United Kingdom, with both France and Italy which have significant presence of
Ae. albopictus that should know an important number of modeled dengue infected air passengers [
20].
Major epidemics have happened in Réunion Island during the last 15 years: 2005–2006 with 244,000 cases of CHIK (near 40% of the population) and 203 deaths; a series of DEN outbreaks in Guadeloupe, Martinique and French Guiana, with an increase in severe forms, particularly dengue haemorrhagic fever [
22]; in Réunion Island, the epidemiology of DEN is moving from an endemo-epidemic situation towards a hyper-endemic situation, and it may affect up to 5% of the population. The epidemiological dynamics observed over this period raise fears of a move towards a situation comparable to that currently seen in Southeast Asia. DEN could become one of the leading causes of hospitalization, especially for children. For instance, during the two 2005 and 2007 DEN epidemics in Guadeloupe (400,500 inhabitants in 2007), the number of clinical cases that led to a medical consultation were respectively 11,500 in 2005 (0.4% of severe cases; serotype 4 predominant) and 19,000 in 2007 (0.8% of severe cases; serotype 2 predominant); in 2018, the number of DEN cases in Guadeloupe and Martinique also raised the epidemic threshold. In December 2013, the first autochthonous cases of CHIK in the Americas were recorded in the French-Dutch Caribbean island of Saint-Martin. The virus spread to other nearby islands of the French West Indies (Saint-Barthélemy, Martinique and Guadeloupe), to the majority of Caribbean islands and to continental America. This epidemic has probably involved more than one million people; in 2014, at least 81,200 presumed clinical cases of CHIK fever were recorded in Guadeloupe, and 72,500 in Martinique [
23]. In Réunion Island again, after the 2017 outbreak of DEN disease, near 8000 cases have been estimated from the beginning of 2018 until the present; concerning the ZIKA epidemic between June 2015 and March 2017, 1141 cases have been reported in French overseas departments, i.e., Guadeloupe (489 cases), Martinique (421) and French Guiana (231).
Faced with public concern and widespread media coverage, national health authorities and policy-makers reacted by implementing national and global health measures to fight these new infections [
24]. In France including ultraperipherical territories, a national plan against the spread (NPS) of dengue, chikungunya and Zika was implemented in 2006 and is updated each year to prevent the expansion of
Ae. albopictus in mainland France, and to organize the surveillance of human cases. Moreover, the French medical and research communities have rapidly developed interdisciplinary programs to better understand and fight these new diseases, for instance the Research and ACTion targeting emerging infectious diseases (REACTing) [
25]. From 2009 to 2016, the general French population’s awareness of these arboviral risks has strongly changed; from a low awareness among the population [
26], citizen views of potential risks has increased during this period with some heterogeneities observed depending on the region and mosquitoe settlement [
27]. Meanwhile, French national health authorities have continuously pursued information campaigns on the potential risks of transmission of these three arboviral infections.
Despite this national effort, no one has tried to quantify the estimation and perception in the different categories of health professionals who are in contact with infected patients of the current and future risk of arboviral diseases. Here, we focused on infectious diseases (ID) physicians because they are well-trained to cope with new emerging infectious threats and also to deliver an objective expert assessment of the real risks of new infections. Moreover, they understand the complexity of vector-borne disease appearance and propagation outside their traditional endemic areas. Our main objective was to evaluate, using an online questionnaire and through a cross-sectional study, their perception of the current and future (10-year) risks of introduction, sporadic case occurence and epidemics of DEN, CHIK and ZIKA in mainland France. We then analyzed the influence of geographic or environmental variables (e.g., presence of insect vectors) and infrastructures (e.g., international airports), as well as that of medical training (e.g., medical school and continuing education), and NPS awareness, on risk perception in ID specialists. Our initial hypothesis was that mosquito biology and international transportation facilities should more significantly influence the perception of a potential threat in this category of health professionals. Therefore, professional respondents’ views of risk perception for potential infections among the general population should be higher among ID physicians located in such departments than in any other departments.
Methods
Data collection and participants
For this study, the French Infectious Diseases Society (SPILF) kindly helped us by sending to the 685 hospital physicians registered on their “Infectio-flash” Discussion List a questionnaire we developed on their perception of the current and future (10-year) risk of introduction, sporadic cases and epidemics for DEN, CHIK and ZIKA, three important vector-borne diseases that are transmitted to humans by two species of mosquitoes (
Ae. aegypti and
Ae. albopictus) [
28]. We only considered mainland France, and excluded all French overseas territories in order to focus on the risk of disease emergence in mainland France, where
Ae. albopictus has settled during the last couple of decades, and
Ae. aegypti is absent. The presence of
Ae. albopictus in France is monitored at the departmental level [
8]. We selected these three diseases due to: i) the strong human transportation connections between mainland France and its tropical overseas territories: French Guiana and French West Indies (DEN, CHIK and ZIKA), Reunion Island (DEN, CHIK), and French Polynesia (DEN, CHIK and ZIKA); ii) the huge numbers of international tourists visiting France each year (up to 83 million visitors in 2016); and iii) the social, economic and political impacts of the CHIK epidemics on Reunion Island in 2005–2006, and in Emilia-Romagna, an Italian region close to southeastern France. All these conditions render certain regions of mainland France potentially vulnerable to these new emerging diseases.
The questionnaire (see Additional file
1: Appendix I) was uploaded on a dedicated Google Forms website and the link was sent to all ID physicians registered with SPILF. Members were informed of this scientific investigation and its issues, were totally free to reply to it, or not, and when replying to the online questionnaire consented to the terms and conditions of this study. The questionnaire was completely anonymous, and practitioners were referenced with a personalized digital code. We did not collect sensitive data, in accordance with current ethics rules (see at: https://ethiquedroit.hypotheses.org/1717#more-1717; see also article 89 from the European rules, April 27th 2016 and article 40.II January 6th 1978).
The sample population (see Additional file
1: Appendix II for further details) was 47,5 years old on average (47 years old for the overall SPILF population, as of 2018], with a median age for MD thesis dissertation being 31 years old (30 years old), a sex ratio of 61/39 (male/female) (48/52), and training in infectioliogy and duration of internship of 1 year; 4 to 5 years of medical specialization plus 1 year of post-internship (for people trained between 1984 and 2017 which included all respondents to the questionnaire (from 2018 to the present, training is only 5 years and infectiologists receive an educational degree called a DES diploma).
Pre-versions of the questionnaire were sent to different public health authorities and medical staff members (regional public health agency - Occitanie, Santé publique France, welfare system - Paris Hospitals, regional hospitals...) in order to improve questions’ accuracy and intelligibility. Even if our questionnaire was not pre-tested on a subset of participants, its validity and reliability were determined according to feedback exchanges on improvements to the questionnaire with these different public health and medical personnel.
The questionnaire included 58 main questions, some of which (e.g., “Today, how do you evaluate the epidemic risk of DEN, CHIK and ZIKA in mainland France?”) were divided into three sub-sections to separately analyze the three infectious diseases. Finally, the questionnaire included 72 (sub-)questions (and thus, variables). Moreover, six additional variables were extracted a posteriori from the information included in the completed questionnaires: latitude and longitude (in degrees, minutes and seconds transformed in decimal degrees) of the respondent’s workplace, presence of an international airport in the respondent’s department (coded 1/0), Ae. albopictus presence (coded 1/0), population size of the city registered as the respondent’s workplace (number of inhabitants), and registered autochthonous cases of DEN and CHIK (number of cases) in the respondent’s department. A French department is an administrative territory, and mainland France includes 96 departments.
Questions and sub-questions were grouped into eight different categories: i) estimation of the total number (current and future) of imported DEN, CHIK and ZIKA cases, in the department and nationwide; ii) perception of sporadic autochthonous case development of DEN, CHIK and ZIKA (current and future) in the department and nationwide; iii) global perception of autochthonous epidemic events of DEN, CHIK and ZIKA (current and future) in the department and nationwide; iv) estimation of the level of concern about the risk of sporadic DEN, CHIK and ZIKA cases (current and future) in the department and nationwide; v) estimation of the level of concern about the global (all three diseases together) risk of epidemic events (current and future) in the department and nationwide; vi) perception of the severity of the clinical consequences (symptoms, complications, mortality…) of DEN, CHIK and ZIKA epidemics; vii) perception of the socio-economic impact of DEN, CHIK and ZIKA; and, viii) qualitative estimation of the communication by public health authorities on DEN, CHIK and ZIKA.
Statistical analysis
All the estimations were rated on a 10-point Likert scale [
29] with 0 being the lowest and 10 the highest level. Reliability of the study instrument was determined using Cronbach’s α. Because we have several questions that are heavily dependent on some core questions, we calculated Cronbach’s α by two different means. Cronbach’s α taking into account all questions yielded a value of 0.938 (number of items is 72) and Cronbach’s α using only main questions yielded a value of 0.789 (number of items is 58), suggesting that the items in our questionnaire have relatively high internal consistency.
First, univariate regression models were used to investigate the relationships between the current and future risk as perceived by hospital practitioners and the different independent variables extracted from the questionnaire (see Table
1), and this for all three diseases. Second, scatter diagrams were used to visualize the plot distribution between current (x-axis) and future (y-axis) disease risk perception for the three infectious diseases. The locally-weighted scatterplot smoothing (LOWESS) non-parametric regression method was used to characterize the main perception trend. A flat plot distribution indicates the perception of a future low/absent disease risk; conversely, a plot distribution near or above the x = y line indicates a future risk perception equivalent to or higher than the current one. Non-parametric and parametric tests were used, when adequate, to evaluate correlations between responses and explanatory variables [
30].
Table 1
Current and future estimation (on a 10-point Likert scale) of the different disease scenarios for dengue (DEN), chikungunya (CHIK) and Zika (ZIKA) (imported or autochthonous cases, and epidemics) within the respondents’ department and nation-wide
Imported cases today | of DEN, in France | 2.570 | 1.558 |
of CHIK, in France | 2.253 | 1.523 |
of DEN, in the department | 1.987 | 1.532 |
of CHIK, in the department | 1.705 | 1.504 |
Imported cases in 10 years | of DEN, in France | 3.949 | 1.844 |
of CHIK, in France | 3.700 | 1.796 |
of DEN, in the department | 3.256 | 1.964 |
of CHIK, in the department | 3.077 | 1.871 |
Autochthonous cases today | of DEN, in France | 3.734 | 2.123 |
of CHIK, in France | 3.696 | 2.162 |
of ZIKA, in France | 3.583 | 2.187 |
of DEN, in the department | 2.456 | 2.246 |
of CHIK, in the department | 2.513 | 2.328 |
of ZIKA, in the department | 2.389 | 2.236 |
Autochthonous cases in 10 years | of all, in France | 4.472 | 2.611 |
of all, in the department | 3.364 | 2.486 |
Epidemic scenario today | of DEN, in France | 1.987 | 1.791 |
of CHIK, in France | 1.974 | 1.721 |
of ZIKA, in France | 1.959 | 1.670 |
of DEN, in the department | 1.597 | 1.858 |
of CHIK, in the department | 1.688 | 1.907 |
of ZIKA, in the department | 1.458 | 1.694 |
Epidemic scenario in 10 years | of all, in France | 3.234 | 2.212 |
of all, in the department | 2.556 | 2.391 |
The relatively small sample size of respondents prevented using many multivariate analyses. However, general linear (GLM) and Generalized Linear Model(s) were used to analyze the influence of the different explanatory variables, and tentatively their two-way interaction terms, on the perception of future risk by developing null and minimal models [
31]. In the GLMM models, variables, such as age and date of medical degree, were used as random variables, and other variables were used as fixed factors. As we did not want to produce the best-fitted explanatory models for the future disease risk perception, the dependent and independent variables were kept untransformed in multivariate models. However, the normality of distribution and homoscedasticity were checked with the Shapiro’s test. To relate the future risk perception variables to independent factors, a Gaussian and a Poisson error model were used, and factors and their interaction terms were selected by using a backward-forward stepwise elimination procedure from the general models and according to the Akaike Information Criterion (AIC) [
31]. Variables were selected using the analysis of variance (ANOVA), with tests specified as “type-III” to assess the effect of each variable after accounting for all other factors [
32].
The robustness of our results relative to sampling heterogeneities was tested using a modified rarefaction analysis. Random samples were generated that contained from 40 to 100% of all questionnaire data for each of the three arboviral diseases. The random sampling was repeated 10 times, and the primary analysis was run using each of these random samples. This allowed us to test the robustness of each result and exclude findings that were significant only due to the presence of outliers.
All analyses were performed using Systat ver. 13.1 (Systat Software Inc., CA) and S-Plus 4.5 (TIBCO Software Inc., CA).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.